Johnson & Johnson (JNJ)

136.91
NYSE : Health Technology
Prev Close 138.10
Day Low/High 136.86 / 138.39
52 Wk Low/High 118.62 / 148.99
Avg Volume 7.52M
Exchange NYSE
Shares Outstanding 2.66B
Market Cap 367.73B
EPS 5.70
P/E Ratio 24.62
Div & Yield 3.60 (2.62%)

Latest News

How to Play the Fed's Gift to the Markets (One Way Is With Netflix)

How to Play the Fed's Gift to the Markets (One Way Is With Netflix)

Wednesday was the first day that Netflix traded on above-average volume since Jan. 24.

Weekly Roundup

Strong earnings boost shares in a rebound week for stocks.

The Rally in Johnson & Johnson Looks Like it has Run Its Course

The Rally in Johnson & Johnson Looks Like it has Run Its Course

Let's check out the charts.

The Perils of Stock Investing: Cramer's 'Mad Money' Recap (Thursday 3/14/19)

The Perils of Stock Investing: Cramer's 'Mad Money' Recap (Thursday 3/14/19)

On the 14th anniversary for 'Mad Money', Jim Cramer talks about how to balance owning index funds and individual stocks.

Jim Cramer: 5 Examples Show Why Stock Investing Is So Difficult

Jim Cramer: 5 Examples Show Why Stock Investing Is So Difficult

Consider these five, right in front of you on this one day, so you get the perils of stock ownership and know how to handle them when they occur.

Video: Jim's Daily Rundown for Thursday

Jim discusses Johnson & Johnson, recent analyst notes on Apple, the cloud kings, and more!

Digging Down on the Dow 30

Digging Down on the Dow 30

Just 13 of the 30 Dow components are in clear uptrends.

Johnson & Johnson Hit With $29 Million Verdict in California Talc Suit

Johnson & Johnson Hit With $29 Million Verdict in California Talc Suit

Loss is latest setback for company's attempts to defuse thousands of claims against it alleging carcinogens in its signature baby powder caused cancer.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

Home Depot and Johnson & Johnson Are Among Stocks Driving the S&P 500

Home Depot and Johnson & Johnson Are Among Stocks Driving the S&P 500

The bull market just had its 10-year anniversary but the gains have not been evenly distributed. A small number of stocks have been the main drivers, and some of these names are not what you might expect.

Jim Cramer: The Real Lesson of the 10-Year Bull Market Anniversary

Jim Cramer: The Real Lesson of the 10-Year Bull Market Anniversary

Did the Fed aid Microsoft? No, Microsoft aided Microsoft. J&J aided J&J. Procter aided Procter.

Weekly Roundup

With China reducing its GDP forecast and Europe's central bank growing cautious, markets turned lower this week.

The 6 Stocks To Watch: Cramer's 'Mad Money' Recap (Thursday 3/7/19)

The 6 Stocks To Watch: Cramer's 'Mad Money' Recap (Thursday 3/7/19)

Jim Cramer's watching six stocks to determine when the selling will end.

Could Kroger Lose the Grocery Wars Over This Challenge?

Allergan is another stock that could stay stuck in its Doldrums. See which of its peers Jim Cramer likes better and why.

Allergan Rises After FDA Accepts License Applications for Botox Supplements

Allergan Rises After FDA Accepts License Applications for Botox Supplements

Allergan wants Botox licenses for pediatric patients.

Jim Cramer: No Room for Cynicism, JNJ's New Depression Drug Is Lifesaving

Jim Cramer: No Room for Cynicism, JNJ's New Depression Drug Is Lifesaving

The approval of esketamine, known as Spravato, for use against severe depression is special -- it is saving lives.

Dow Ends Lower as Investors Eye Details From Trade Talks, Oil Prices Tumble

Dow Ends Lower as Investors Eye Details From Trade Talks, Oil Prices Tumble

The Dow Jones Industrial Average ended the day lower as details over the trade talks between the U.S. and China are awaited and oil prices tumble.

TheStreet Quant Rating: B+ (Buy)